Expanding Clinical Use of Sodium-glucose Cotransporter-2 Inhibitors?

被引：0
|
作者：
Dhawan, Richa [1 ]
Chaney, Mark A. [2 ]
机构：
[1] Univ Chicago, Med Ctr, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL USA
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2024年 / 38卷 / 10期
关键词：
D O I：
10.1053/j.jvca.2024.06.039
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：2135 / 2138
页数：4
相关论文
共 50 条
  • [21] Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy
    Nalbandian, A.
    Teruya, S.
    Smiley, D.
    Helmke, S.
    Yarmohammadi, H.
    Maurer, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 35 - 36
  • [22] Temporal trends in the use of sodium-glucose cotransporter-2 inhibitors: the global DISCOVER study
    Ji, L.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Khunti, K.
    Pocock, S.
    Shestakova, M. V.
    Shimomura, I.
    Surmont, F.
    Tangy, F.
    Kosiborod, A. I.
    DIABETOLOGIA, 2018, 61 : S310 - S311
  • [23] Physicians' Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors
    Jabbour, Serge A.
    Ibrahim, Nasrien E.
    Argyropoulos, Christos P.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [24] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Handelsman, Yehuda
    ADVANCES IN THERAPY, 2019, 36 (10) : 2567 - 2586
  • [25] Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes
    Peacock, Sharon C.
    Lovshin, Julie A.
    Cherney, David Z. I.
    ANESTHESIA AND ANALGESIA, 2018, 126 (02): : 699 - 704
  • [26] Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
    Shakour, Neda
    Karami, Shima
    Iranshahi, Mehrdad
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [27] Potential Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in the Perioperative Period
    Hulst, Abraham H.
    Hermanides, Jeroen
    DeVries, J. Hans
    Preckel, Benedikt
    ANESTHESIA AND ANALGESIA, 2018, 127 (01): : 306 - 307
  • [28] Potential Utility of Sodium-Glucose Cotransporter-2 Inhibitors in Treating Myocarditis
    Kim, Michael H.
    Suri, Yash
    Rajendran, Iniya
    Pineda, J. R. Exequiel T.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (02): : e33 - e34
  • [29] Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
    Singh, Awadhesh Kumar
    ENDOCRINE PRACTICE, 2022, 28 (10) : 1107 - 1108
  • [30] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Yehuda Handelsman
    Advances in Therapy, 2019, 36 : 2567 - 2586
12345